| 摘要 |
<p>Disclosed are MC-4 and/or MC-3 receptor ligands, the ligands having a structure according to Formula (I): wherein R<2>, R<4>, R<4'>, R<5>, R<6>, R<6'>, R<7>, R<8>, R<8'>, R<9>, R<9'>, R<10>, Ar, Z<1>, Z<2>, Z<3>, X, B, D, p, q, r and s are as described in the specification and claims, and optical isomers, diastereomers or enantiomers thereof; pharmaceutically-acceptable salts, hydrates, and biohydrolyzable esters, amides or imides thereof. Also disclosed are pharmaceutical compositions comprising the ligands of Formula (I), as well as methods of treating diseases mediate by the MC-4/MC-3 receptors, as described in the Detailed Descriptions section of the specification.</p> |
